BERNSTEIN HAROLD (President, R&D & CMO) sold 51.5% of their position (10.29K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $270.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/4/2026ACC: 0002050172-26-000034
Officer· President, R&D & CMO
Since Mar 2026
-10.29K
Net shares
Net seller
$270.1K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10.29K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−4.48K
Price / share
$26.38
Trade value
$118.19K
% of position
22.4%
9/2/2026
20K→15.52K
Common Stock
Direct
Shares
−625.00
Price / share
$27.12
Trade value
$16.95K
% of position
4.0%
9/2/2026
15.52K→14.89K
Common Stock
Direct
Shares
−5.13K
Price / share
$26.01
Trade value
$133.45K
% of position
34.4%
9/3/2026
14.89K→9.76K
Common Stock
Direct
Shares
−59.00
Price / share
$25.78
Trade value
$1.52K
% of position
0.6%
9/3/2026
9.76K→9.71K
Total
Net shares
−10.29K
Net value
-$270.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −4.48K | $26.38 | $118.19K | 22.4% | 20K | 15.52K |
| Common Stock Direct | 9/2/2026 | S · Sale | −625.00 | $27.12 | $16.95K | 4.0% | 15.52K | 14.89K |
| Common Stock Direct | 9/3/2026 | S · Sale | −5.13K | $26.01 | $133.45K | 34.4% | 14.89K | 9.76K |
| Common Stock Direct | 9/3/2026 | S · Sale | −59.00 | $25.78 | $1.52K | 0.6% | 9.76K | 9.71K |
| Total | −10.29K | -$270.11K | ||||||
Derivative Transactions0
No derivative transactions reported